Literature DB >> 75444

Plasmapheresis in Raynaud's disease.

G Talpos, M Horrocks, J M White, L T Cotton.   

Abstract

Understanding of the pathogenesis, clinical course, and treatment of Raynaud's disease is confused and unsatisfactory, and no success in treatment can be promised. Five patients with severe Raynaud's disease, who had not responded to other forms of treatment, were treated by plasmapheresis, which produced a striking improvement. Ultrasonic velocimetry showed that segments of digital arteries which had been thought to be permanently occluded became patent and remained patent after plasmapheresis.

Entities:  

Mesh:

Year:  1978        PMID: 75444     DOI: 10.1016/s0140-6736(78)91205-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Plasma exchange and plasmapheresis.

Authors:  N A Buskard
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

2.  Controlled trial of plasma exchange in treatment of Raynaud's syndrome.

Authors:  M J O'Reilly; G Talpos; V C Roberts; J M White; L T Cotton
Journal:  Br Med J       Date:  1979-04-28

3.  Prostaglandin E1 therapy for digital ulcers in scleroderma.

Authors:  M Baron; G Skrinskas; M B Urowitz; P N Madras
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

4.  Electrically heated gloves for intermittent digital ischaemia.

Authors:  G E Kempson; D Coggon; E D Acheson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

5.  Electrically heated gloves in children with Raynaud's phenomenon.

Authors:  M P White; K M Goel
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

6.  Effect of plasma exchange on blood viscosity and cerebral blood flow.

Authors:  M M Brown; J Marshall
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12

Review 7.  Blood rheology.

Authors:  J Stuart; M W Kenny
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

8.  Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

Authors:  J van der Maulen; A A Wouda; E Mandema; T H The
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Comparison of behavioral treatments for Raynaud's disease.

Authors:  J B Jobe; J B Sampson; D E Roberts; J A Kelly
Journal:  J Behav Med       Date:  1986-02

10.  Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.

Authors:  G C Tsokos; J E Balow; D P Huston; N Wei; J L Decker
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.